SCHEMBL2962848

SCHEMBL2962848

CC1=Cc2cc(Br)ccc2C1c1cccc2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RCE1 Q9Y256 1/20 0.38
SLC6A4 P31645 6/20 0.35
SLC6A2 P23975 5/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
EGFR P00533 2/20 0.34
ERBB2 P04626 2/20 0.34
CYP2A6 P11509 2/20 0.34
ALDH1A1 P00352 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
SLC6A3 Q01959 2/20 0.33
CYP1A2 P05177 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2969249 0.90 KDM1A (0.37) KDM1AMEN1KMT2ARCE1SLC6A4
SCHEMBL5477612 0.84 KDM1A (0.44) KDM1AMEN1KMT2ARCE1SLC6A4
SCHEMBL2975457 0.83 MAPK1 (0.35) SLC6A4SLC6A2HTR2AHTR2CALDH1A1
SCHEMBL2973079 0.79 HTR2C (0.38) SLC6A4SLC6A2HTR2AHTR2CALDH1A1
SCHEMBL2971669 0.78 HDAC4 (0.36) KDM1AMEN1KMT2ASLC6A4SLC6A2
SCHEMBL2970237 0.78 CYP2A6 (0.44) KDM1ASLC6A4SLC6A2HTR2CEGFR
SCHEMBL2962492 0.77 KDM1A (0.38) KDM1AMEN1KMT2ARCE1SLC6A4
SCHEMBL22777121 0.76 KDM1A (0.39) KDM1AMEN1KMT2ARCE1SLC6A4
SCHEMBL2964782 0.76 KDM1A (0.40) KDM1AMEN1KMT2ARCE1SLC6A4
SCHEMBL2970945 0.74 TP53 (0.35) MEN1KMT2ASLC6A4SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 KDM1A 3280/4885MEN1 750/4885KMT2A 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.